2.21 (-%)
As of Nov 01, 2024
Source:
Caribou Biosciences, Inc. is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases.
| Country | United States |
| Headquarters | berkeley, california |
| Phone Number | ( 510 ) 982-6030 |
| Industry | manufacturing |
| CEO | Rachel E. Haurwitz |
| Website | www.cariboubio.com |